90 Ten
90TEN is an independent London-based healthcare communications consultancy serving pharmaceutical, biotech, and public health clients through three divisions (PR, medical communications, and health advocacy) using a proprietary Feel-Think-Do™ behavioral science methodology, with a stated client base covering over half of the top 20 global pharma companies.
- Company typePrivate
- Founded2020
- HeadquartersLondon, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingServices
What 90 Ten does
90TEN is a London-headquartered, independent healthcare communications consultancy founded in 2001, operating with approximately 70 staff across offices in London and Washington DC. The firm serves pharmaceutical, biotechnology, consumer health, and public health clients, with a stated client base covering over half of the top 20 global pharmaceutical companies. Services are delivered on a project and retainer basis through three integrated sub-brands: 90TEN Communications (public relations), 90TEN Medical (medical communications and education, staffed by academic scientists), and 20SENSES (health advocacy and patient engagement).
The firm's differentiating technical asset is the proprietary Feel-Think-Do™ methodology, an evidence-based behavioral science suite of tools co-developed with behavioral psychologists to map the emotional, cognitive, and environmental drivers behind communications challenges. This methodology is applied across all client engagements to design campaigns intended to drive measurable behavior change, with documented outcomes such as the My Journey HIV campaign co-created with the HIV community. Delivery is supported by a channel partnership with Baird's CMC, which extends effective reach to communications specialists in over 50 countries.
Since April 2020, 90TEN has operated as a wholly-owned subsidiary of Envision Pharma Group, a global evidence-based communications and technology provider backed by Ardian and GHO Capital. The parent group has approximately 800 employees across 14 offices and four continents, giving 90TEN access to the iEnvision technology platform, strategic publications planning, and broader medical communications capabilities. 90TEN retains its own brand, leadership (CEO Carole North, Chairman and co-founder Paul Tanner), and Feel-Think-Do™ methodology. Pricing is quote-based and varies by project scope, with no publicly disclosed revenue. The firm holds no patents and no AI/ML capabilities are documented; its competitive moat rests on methodology, talent retention, and enterprise pharma client relationships, validated by repeated industry awards between 2016 and 2020.
90 Ten firmographics
Firmographics- Name
- 90 Ten
- Legal name
- 90TEN Group Limited
- Website
- https://90ten.co.uk
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- 90TEN is an independent London-based healthcare communications consultancy serving pharmaceutical, biotech, and public health clients through three divisions (PR, medical communications, and health advocacy) using a proprietary Feel-Think-Do™ behavioral science methodology, with a stated client base covering over half of the top 20 global pharma companies.
- Ownership category
- akta.pro rank
90 Ten industry classification
Industry- Product category
- Healthcare communications consultancy
- NAICS
- Advertising, Public Relations, and Related Services (5418), Public Relations Agencies (541820), Other Scientific and Technical Consulting Services (54169), Health Care and Social Assistance (62)
- SIC
- Services-Advertising Agencies (7311), Services-Health Services (8000)
- akta.pro primary industry
- Healthcare & Life Sciences PR (MPAAADAD)
- akta.pro secondary industries
- Healthcare & Life Sciences PR (BPAFADAJ), Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)
Keywords
Where 90 Ten is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
90 Ten business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Healthcare Communications Consultancy Services: 90TEN generates revenue through providing PR, medical communications, and patient advocacy services to pharmaceutical, biotech, consumer health, and public health clients. Services are delivered on a project and retainer basis, serving enterprise healthcare companies.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
90 Ten product offering
Product offeringCore offering
90TEN is a global healthcare communications consultancy providing public relations, medical communications, medical education, and patient advocacy services to pharmaceutical, biotech, consumer health, and public health organizations. The firm operates through three specialist divisions (90TEN Communications, 90TEN Medical, 20SENSES) unified by its proprietary Feel-Think-Do™ behavioral science methodology. Services are delivered on a project and retainer basis to enterprise healthcare clients, with over half of the top 20 global pharma companies as clients.
Product overview
90TEN is a global healthcare communications consultancy operating as a unified group with three specialist divisions: 90TEN Communications (public relations), 90TEN Medical (medical communications and education), and 20SENSES (health advocacy consultancy). These divisions are unified by the proprietary Feel-Think-Do™ behavioral science methodology, which underpins all service offerings to maximize brand and health outcomes.
Differentiator
Problem solved
Functional benefit
Brands
- 90TEN Medical: Medical communications and education consultancy staffed by academic scientists and healthcare marketing experts, providing medical and scientific strategy development and communication of medical milestones
- 90TEN Communications
- 20SENSES
Products and services
- 90TEN Communications Public relations consultancy division of 90TEN providing communications services to the healthcare sector, focusing on pharmaceuticals, biotech, consumer health, and public health, using behavioral science methodologies to drive meaningful change.
- 90TEN Medical Medical communications and education consultancy division of 90TEN, staffed by academic scientists and healthcare marketing experts, offering medical and scientific strategy development and the coordination and communication of medical milestones for healthcare clients.
- 20SENSES Health advocacy consultancy division of 90TEN specializing in patient engagement, public health, and medical education, using a co-creation approach with patients and healthcare professionals to build advocacy and grassroots support for health campaigns.
- Feel-Think-Do™ behavioral science methodology Proprietary evidence-based suite of behavioral science tools developed by 90TEN with behavioral psychologists, designed to understand human emotions, thought processes, and environmental factors behind communications challenges and deliver tailored, targeted communications that inspire meaningful and positive behavior change.
Quantifiable outcome
- Nearly a third of gay men living with HIV took steps to improve their future health through the My Journey campaign co-created with the HIV community
Companies that use 90 Ten
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
90 Ten technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
90 Ten partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- Envision Pharma Groupcore90TEN was acquired by Envision Pharma Group, a global provider of evidence-based communication services and industry-leading technology solutions. The acquisition brings 90TEN's behavioral science, creativity, and insight-driven communications expertise to Envision's broader portfolio. 90TEN retains its brand and service offering while gaining access to Envision's global infrastructure including technology platform iEnvision, strategic publications planning, medical strategy, and expanded geographic reach.
- Baird's CMC Networkminor90TEN collaborates with Baird's CMC network of agencies, which provides direct access to communications specialists in over 50 countries and across all continents of the globe. This partnership extends 90TEN's global reach for serving multinational healthcare clients.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
90 Ten competitors and assessment
Company assessmentBroad incumbents
- Ogilvy Health: Healthcare communications arm of WPP/Ogilvy offering PR, medical education, and brand communications globally. Competes for the same top-20 pharma clients but as part of a much larger, broader portfolio; 90TEN's prior hire Rick Evans came from this firm.
- MSL Group (Publicis Health): Global public relations and integrated communications network with a strong healthcare practice. Directly competes for pharma communications and patient advocacy briefs as part of the Publicis Health portfolio.
- Edelman (Health practice): Global communications firm with a dedicated health practice providing PR, medical communications, and policy work to top pharma clients. Comparable offering as part of a broader portfolio but with materially larger scale.
Direct peers
- Syneos Health Communications: Communications arm of Syneos Health offering medical communications, PR, and patient engagement for pharma/biotech. Comparable in customer base, offering breadth, and integration with broader pharma services.
- Havas Life (formerly Havas Health & You): Global healthcare communications network providing medical communications, PR, and patient engagement services to pharma and biotech clients. Direct competitor for top-20 pharma accounts with comparable behavioral science and creative capabilities.
- Real Chemistry: Healthcare and life sciences communications and data-driven marketing agency serving top pharma clients across PR, medical communications, and patient engagement. Comparable in scale, customer profile, and integrated offering.
- GCI Health: Specialist healthcare public relations and communications agency serving pharma, biotech, and consumer health clients globally. Closely comparable to 90TEN in offering, target customers (top-20 pharma), and behavioral/creative campaign-led positioning.
- WE Communications: Global communications agency with a deep health practice serving pharma, biotech, and consumer health clients across PR, medical education, and patient advocacy. Comparable in offering mix, customer profile, and behavioral-science-led campaign work.
- Inizio Evoke (formerly Huntsworth Health): Global healthcare communications and advisory group serving pharma, biotech, and consumer health. One of the closest direct peers to 90TEN in offering mix, customer profile, and European HQ base.
Regional players
- Aurora Healthcare Communications: UK-based healthcare communications consultancy providing PR, medical education, and patient engagement to pharma clients. Comparable in service mix and target customers but primarily focused on the UK/European market versus 90TEN's transatlantic reach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
90 Ten social profiles
Digital presence90 Ten compliance and trust
Trust signalCompliance1 record
90 Ten financial estimates
Financial estimateRevenue estimate
Valuation estimate
90 Ten leadership team
Management profileNumber of profiles
Profiles10 records
90 Ten subsidiaries and ownership
Company hierarchySubsidiaries3 records
90 Ten funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
90 Ten M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 90 Ten
What does 90 Ten do?
90TEN is a global healthcare communications consultancy providing public relations, medical communications, medical education, and patient advocacy services to pharmaceutical, biotech, consumer health, and public health organizations. The firm operates through three specialist divisions (90TEN Communications, 90TEN Medical, 20SENSES) unified by its proprietary Feel-Think-Do™ behavioral science methodology. Services are delivered on a project and retainer basis to enterprise healthcare clients, with over half of the top 20 global pharma companies as clients.
Is 90 Ten a public or private company?
90 Ten is a private company. It is classified as corporate owned and is currently operating.
When was 90 Ten founded?
90 Ten was founded in 2020. It employs 51 to 100 people.
Where is 90 Ten based?
90 Ten is headquartered in London, United Kingdom, in the Europe region.
How does 90 Ten make money?
One revenue line is on record: healthcare Communications Consultancy Services.
Who are 90 Ten's main competitors?
Broad incumbents on record are Ogilvy Health, MSL Group (Publicis Health) and Edelman (Health practice). Direct peers are Syneos Health Communications, Havas Life (formerly Havas Health & You), Real Chemistry, GCI Health, WE Communications and Inizio Evoke (formerly Huntsworth Health). Aurora Healthcare Communications is listed as a regional player.
Does 90 Ten have an API?
No public API is recorded for 90 Ten.
What industry is 90 Ten in?
90 Ten's product category is Healthcare communications consultancy. Its primary akta.pro industry code is MPAAADAD, Healthcare & Life Sciences PR, with a secondary code of BPAFADAJ, Healthcare & Life Sciences PR. Its NAICS code is 5418 and its SIC code is 7311.